Cargando…

Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States

BACKGROUND: This study analyses treatment patterns, health care resource utilization (HCRU), and costs in patients with myelofibrosis (MF) and a subgroup treated with ruxolitinib (RUX). MATERIALS AND METHODS: Treatment patterns, all-cause and MF-related HCRU, and costs were analyzed in adults with M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Copher, Ronda, Kee, Arianna, Gerds, Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Health Outcomes and Economics of Cancer Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914486/ https://www.ncbi.nlm.nih.gov/pubmed/35274711 http://dx.doi.org/10.1093/oncolo/oyab058

Ejemplares similares

Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
por: McArthur, Grant A., et al.
Publicado: (2017)

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors
por: George, Saby, et al.
Publicado: (2021)

Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S
por: Yang, Xiaoqin, et al.
Publicado: (2021)

Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020
por: Perera, Nirosha D, et al.
Publicado: (2023)

Costs of Cancer Care Across the Disease Continuum
por: Kaye, Deborah R., et al.
Publicado: (2018)

“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management
por: Shickh, Salma, et al.
Publicado: (2022)

Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
por: Ludwig, Heinz, et al.
Publicado: (2020)

Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data
por: Raphael, Jacques, et al.
Publicado: (2022)

Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma
por: Postmus, Douwe, et al.
Publicado: (2017)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
por: Choi, Jin G., et al.
Publicado: (2018)

Women Who Are Young, Non‐White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed‐Effects Regression Analysis
por: Politi, Mary C., et al.
Publicado: (2020)

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Zheng, Ying, et al.
Publicado: (2021)

Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta‐Analysis
por: Nielson, Carrie M., et al.
Publicado: (2021)

COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
por: Borno, Hala T, et al.
Publicado: (2022)

Temporal Trends in Inpatient Oncology Census Before and During the COVID‐19 Pandemic and Rates of Nosocomial COVID‐19 Among Patients with Cancer at a Large Academic Center
por: Zubiri, Leyre, et al.
Publicado: (2021)

Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID‐19
por: Klein, Isaac A., et al.
Publicado: (2021)

Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act
por: Roth, Michael, et al.
Publicado: (2022)

Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
por: Tan, Ruoding, et al.
Publicado: (2022)

Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
por: Azoulay, Laurent
Publicado: (2022)

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum
por: Lai-Kwon, Julia, et al.
Publicado: (2022)

Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda
por: Kizub, Darya A, et al.
Publicado: (2022)

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
por: Bhatt, Sunil, et al.
Publicado: (2022)

Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
por: Gupta, Arjun, et al.
Publicado: (2023)

The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
por: Flick, E Dawn, et al.
Publicado: (2023)

The Utility of Pain Scale to Assess Verifiable vs Non-Verifiable Pain in United States Emergency Departments
por: Xu, K. Tom, et al.
Publicado: (2021)

Homecare and Healthcare Utilization Errors Post–Neonatal Intensive Care Unit Discharge
por: Patel, Rupalee, et al.
Publicado: (2017)

United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
por: Limkakeng, Alexander T., et al.
Publicado: (2021)

Healthcare resource utilisation pattern and costs associated with herpes simplex virus diagnosis and management: a systematic review
por: Lee, Shaun Wen Huey, et al.
Publicado: (2022)

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study
por: Brecker, Stephen, et al.
Publicado: (2014)

Management of Sickle Cell Disease Super Utilizers
por: Johnson, Gary A.
Publicado: (2017)

Utilization of Educational Videos to Improve Communication and Discharge Instructions
por: Wray, Alisa, et al.
Publicado: (2021)

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
por: Gandra, Shravanthi R., et al.
Publicado: (2016)

Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial
por: Bertelsen, Jannik B, et al.
Publicado: (2018)

Variability in the Initial Costs of Care and One-Year Outcomes of Observation Services
por: Abbass, Ibrahim
Publicado: (2015)

Estimating the Cost of Care for Emergency Department Syncope Patients: Comparison of Three Models
por: Probst, Marc A., et al.
Publicado: (2017)

Utility of the History and Physical Examination in the Detection of Acute Coronary Syndromes in Emergency Department Patients
por: Dezman, Zachary DW, et al.
Publicado: (2017)

Cost-effectiveness of running a paediatric oncology unit in Ethiopia
por: Kiros, Mizan, et al.
Publicado: (2023)

Disparities in health in the United States: An overview of the social determinants of health for otolaryngologists
por: Bergmark, Regan W., et al.
Publicado: (2017)

Reassessing After-Hour Arrival Patterns and Outcomes in ST-Elevation Myocardial Infarction
por: Langabeer, James, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_avqpenrusbvvnfsgvaa1k06tqc